GSK, CureVac to make COVID-19 vaccines aimed at new variants


U.K.-based drugmaker GlaxoSmithKline and Germany’s CureVac say they plan to collaborate to develop new vaccines that can target emerging variants of COVID-19…

Source

Leave a Reply